Journals / Fırat Üniversitesi Sağlık Bilimleri Tıp Dergisi / 2015 / Cilt: 29 - Sayı: 3

Plasmapheresis Therapy in Acute Critical Leg Ischemia Associated with Catastrophic Antiphospholipid Syndrome

Katastrofik Antifosfolipid Sendromuna Bağlı Akut Kritik Bacak İskemisinde Plazmaferez Tedavisi

Pages
143–145
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The case is reported and discussed with literature review.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Antiphospholipid syndrome is an autoimmune disease associated with repetitive thrombosis of both arterial and venous vasculature.
📊
Key Findings & Data:Anti-aggregant and anti-coagulant agents can be used in treatment of these thrombosis.
💡
Conclusion & Impact:The case is reported and discussed with literature review.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Antiphospholipid syndrome is an autoimmune disease associated with repetitive thrombosis of both arterial and venous vasculature. Anti-aggregant and anti-coagulant agents can be used in treatment of these thrombosis. This case with antiphospholipid syndrome and acute leg ischemia which was nonresponsive to these treatment modalisties was treated with plasmapheresis successfully. The case is reported and discussed with literature review.

Özet

Antifosfolipid sendromu tekrarlayan arteryel ve venöz trombozlar ile seyreden otoimmun bir hastalıktır. Tedavisinde antiagregan ve antikoagülan ilaçlar kullanılabilir. Bu tedavilere cevap vermeyen ve akut kritik bacak iskemisi ile başvuran antifosfolipid sendromlu olguda plazmaferez tedavisi başarı ile uygulanmıştır. Olgunun sonuçları literatür eşliğinde gözden geçirilmiştir.

🔖

Cite This Article

TANYELİ, Ö., GÖRMÜŞ, Z. I. S., KUTLU, S. (2022). Plasmapheresis Therapy in Acute Critical Leg Ischemia Associated with Catastrophic Antiphospholipid Syndrome. Fırat Üniversitesi Sağlık Bilimleri Tıp Dergisi, Cilt: 29 - Sayı: 3, 143–145. https://ajindex.com/articles/514612

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 752-763
  2. Thomas RH. Hypercoagulability syndromes. Arch Intern Med 2001; 161: 2433-2439
  3. Park KW. The antiphosholipid syndrome. Int Anesthesiol Clin 2004; 42: 45-57
  4. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheum 1999; 42: 1309- 1311
  5. Santoro SA: Antiphospholipid antibodies and thrombotic predisposition: Underlying pathogenetic mechanisms. Blood 1994; 83: 2389-2391
  6. Greaves M, Cohen H, MacHin SJ, Mackie I. Guidelines on the investigation and management of the antiphospholipid syndrome. British Journal of Haematology 2000; 109: 704- 715
  7. Gezer S. Antiphospholipid syndrome. Dis Mon 2003; 49: 696-741
  8. Erkan D, Merrill JT, Yazıcı Y, et al. High risk of thrombosis rate after fetal loss in antiphospholipid syndrome: Effective prophylaxis with aspirin. Arthritis Rheum 2001; 44: 1466- 1471
  9. Asherson RA, Cervera R, Piette JC, et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) 1998; 77: 195-207.